2,290 reports of this reaction
3.1% of all HUMAN IMMUNOGLOBULIN G reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for HUMAN IMMUNOGLOBULIN G, manufactured by ADMA Biologics, Inc.. There are 2,290 FDA adverse event reports linking HUMAN IMMUNOGLOBULIN G to DRUG INEFFECTIVE. This represents approximately 3.1% of all 73,013 adverse event reports for this drug.
Patients taking HUMAN IMMUNOGLOBULIN G who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among HUMAN IMMUNOGLOBULIN G users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for HUMAN IMMUNOGLOBULIN G:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 2,290 FDA reports for HUMAN IMMUNOGLOBULIN G. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.1% of all adverse event reports for HUMAN IMMUNOGLOBULIN G, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking HUMAN IMMUNOGLOBULIN G, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.